Skip to content
Longterm Wiki

4J Therapeutics — Locked Nucleic Acid Technology

$2.5M
Funder
Recipient
4J Therapeutics
Program
Date
Nov 2023
Source
Notes

[Scientific Research] Open Philanthropy recommended an investment of $2,499,993 in 4J Therapeutics to support the development and commercialization of locked nucleic acid technology for therapeutic and prophylactic use against respiratory viruses. This falls within our work on scientific research.

Other Grants by Coefficient Giving

2625
Showing 10 of 2625 grants
4J Therapeutics — Locked Nucleic Acid Technology | Coefficient Giving | Grants | Longterm Wiki